Clinical Trials Logo

Filter by:
  • Terminated  
  • Page [1]
NCT ID: NCT04414319 Terminated - SARS-CoV 2 Clinical Trials

Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly

CovAged
Start date: April 15, 2020
Phase:
Study type: Observational

In most diseases, older people have less typical symptomatology than that described for younger people. The investigators therefore hypothesize that within the framework of coronavirus disease 19, the clinical pictures in the elderly will present specificities that will need to be described. Moreover, since infection by the severe acute respiratory syndrome (SARS-CoV-2) virus is new to humans, the investigators do not yet have sufficient information on the fate of the elderly, in terms of loss of autonomy, rehospitalization, institutionalization, mortality, etc. the investigators therefore assume that the clinical pictures in the elderly will present specificities that will need to be described. The investigators hypothesize that an acute infection of this type will have short-, medium-, and long-term repercussions in the elderly.

NCT ID: NCT03656640 Terminated - Autoimmune Diseases Clinical Trials

Trial Assessing Safety and Efficacy of Gammanorm® in Autoimmune Diseases

Start date: November 23, 2016
Phase:
Study type: Observational

This observational trial assesses the safety and efficacy of Gammanorm® in autoimmune diseases.

NCT ID: NCT03435458 Terminated - Maternal Obesity Clinical Trials

Balloon to Induce Labor in Generous Women.

BIGW
Start date: June 26, 2020
Phase: Phase 3
Study type: Interventional

The rate of obesity increases continuously in France as in many developing countries.The risk of cesarean delivery is increased in obese compared to normal-weight women and postpartum complications as infections, thromboembolic events and related maternal death, are more common among obese women who deliver by cesarean than both normal-weight women with caesarean deliveries and obese women with vaginal deliveries. Unfortunately, obesity is associated with a higher rate of failed induction requiring a cesarean delivery and especially in nulliparous. Methods of induction for obese women have to be improved to decrease the c-section rate but investigators should also be cautious on the type and dose of PG not to affect the neonatal wellbeing associated with uterine hyperstimulation. The aim of this study is to demonstrate the efficacy of the association of mechanical and pharmacological cervical ripening (balloon catheter plus 50 µg oral prostaglandin E1) versus pharmacological cervical ripening alone (50 µg oral prostaglandin E1) to reduce the rate of caesarean sections in nulliparous obese women.

NCT ID: NCT03328338 Terminated - Cardiac Amyloidosis Clinical Trials

Mitochondrial Function in Transthyretin Amyloidosis

MIT-Amylose
Start date: July 17, 2018
Phase:
Study type: Observational

Hereditary (familial) amyloidosis arising from the misfolding of a mutated or variant transthyretin, is the most frequent form of amyloid cardiomyopathy in the Caribbean basin. Affected organs invariably harbor extracellular amyloid deposits in the myocardium. Circulating or pre-fibrillar amyloidogenic proteins are implicated in the disruption of cell function. The investigators aim is to demonstrate that transthyretin mediated amyloid disease alter the mitochondrial function of cardiac cells.

NCT ID: NCT03161444 Terminated - HIV Infections Clinical Trials

Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection.

ZIKAVIH
Start date: March 21, 2017
Phase: N/A
Study type: Interventional

This study will estimate the cumulative incidence of Zika infection at the end of the first epidemic in the French West Indies in a sample of patients followed for HIV infection.

NCT ID: NCT02704312 Terminated - Breast Cancer Clinical Trials

Dosimetric Comparison of Doses in Both Positions (Prone and Decubitus) for Patient With Breast Cancer

PROCUBITUS
Start date: November 30, 2015
Phase: N/A
Study type: Interventional

Compare dosimeters in both positions (prone and decubitus) for each patient

NCT ID: NCT00617721 Terminated - Scott Syndrome Clinical Trials

Markers of Defective Membrane Remodelling in Scott-like Syndromes

Start date: June 2008
Phase: N/A
Study type: Observational

Purpose: Identification of the gene(s) involved in plasma membrane remodelling. Identification of the circulating markers affected by the defective membrane remodelling in a collection of families with unexplained provoked hemorrhages and evaluation of their prognosis value in the assessment of the hemostatic cellular response.Hypothesis: Scott syndrome is rare a familial disorder characterized by provoked haemorrages in homozygous-type patients due to isolated membrane remodelling deficiency. Membrane remodelling is necessary for cellular hemostatic responses.